We conducted a randomized , double-blind , placebo-controlled , multicenter trial in which 10,007 healthy infants and young children ( 6 to 35 months of age ) were randomly assigned in a 1:1 ratio to receive two intramuscular doses of either EV71 vaccine or placebo , 28 days apart .